NASDAQ: VYNE
VYNE Therapeutics Inc.CIK 0001566044 · Pharmaceutical Preparations
Micro
Revenue $570K
Assets $26M
as of Jul 12, 2026
Each report below shows a 3-bullet preview. Free accounts read 3 full reports a month — narrative summary, section diffs, and EDGAR-cited quotes.
Sign up freeWant to see a complete report first? Today's free report (SLP 10-Q) is open in full — no account needed.
8-K
Filed Jul 10, 2026
· Period ending Jul 10, 2026
Summary not yet generated.
424B3
Filed Jun 15, 2026
Summary not yet generated.
Partner
Trade VYNE commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
8-K
Filed May 21, 2026
· Period ending May 21, 2026
Summary not yet generated.
10-Q
Filed May 15, 2026
· Period ending Mar 31, 2026
Summary not yet generated.
8-K
Filed Mar 11, 2026
· Period ending Mar 11, 2026
Summary not yet generated.
10-K
Filed Feb 27, 2026
· Period ending Dec 31, 2025
Summary not yet generated.
10-Q
Filed Nov 6, 2025
· Period ending Sep 30, 2025
Summary not yet generated.
10-K
Filed Mar 6, 2025
· Period ending Dec 31, 2024
Summary not yet generated.